Financier | Commitments |
---|---|
IDA Credit | 15.00 |
P160947
Closed
Edith Digwaleu-Kariko
Independent State of Papua New Guinea
Papua New Guinea
October 26, 2016
(as of board presentation)
May 31, 2017
September 25, 2017
US$ 15.00 million
National Department of Health
2017
US$ 15.00 million
B
March 15, 2024
June 15, 2024
Yes
BANK APPROVED
Financier | Commitments |
---|---|
IDA Credit | 15.00 |
Product Line | IBRD/IDA |
---|---|
IBRD Commitment | N/A |
IDA Commitment | 15.00 |
IBRD + IDA Commitment | 15.00 |
Lending Instrument | |
---|---|
Grant Amount | N/A |
Total Project Cost** | 15.00 |
Period | Financier | Transaction Type | Amount (US$) |
---|---|---|---|
Jun 21, 2024 | IDA-60670 | Loan Disb | 98,404.74 |
Jun 1, 2024 | IDA-60670 | Int Charges | 4,387.22 |
Jun 1, 2024 | IDA-60670 | Loan Repay | 242,406.34 |
Feb 5, 2024 | IDA-60670 | Loan Disb | 525,439.00 |
Feb 6, 2024 | IDA-60670 | Loan Disb | 89,814.41 |
May 31, 2017 | IDA-60670 | Loan Commitment | 15,000,000.00 |
May 13, 2024 | IDA-60670 | Loan Disb | 44,675.06 |
Jun 1, 2024 | IDA-60670 | Int Charges | 35,682.43 |
Jun 1, 2024 | IDA-60670 | Int Charges | 35,682.43 |
Jun 1, 2024 | IDA-60670 | Int Charges | 57,762.75 |
May 13, 2024 | IDA-60670 | Loan Disb | 79,017.14 |
May 13, 2024 | IDA-60670 | Loan Disb | 50,623.78 |
May 13, 2024 | IDA-60670 | Loan Disb | 28,024.51 |
Mar 13, 2024 | IDA-60670 | Loan Disb | 41,549.74 |
Mar 13, 2024 | IDA-60670 | Loan Disb | 37,209.16 |
Feb 15, 2024 | IDA-60670 | Loan Disb | 48,397.94 |
Feb 23, 2024 | IDA-60670 | Loan Disb | 40,104.36 |
Feb 13, 2024 | IDA-60670 | Loan Disb | 73,170.82 |
Jan 30, 2024 | IDA-60670 | Loan Disb | 22,145.77 |
Apr 23, 2021 | IDA-60670 | Loan Disb | 8,628.04 |
Apr 19, 2021 | IDA-60670 | Loan Disb | 11,482.08 |
May 24, 2021 | IDA-60670 | Loan Disb | 11,452.89 |
Jun 2, 2021 | IDA-60670 | Loan Disb | 14,819.62 |
Apr 30, 2021 | IDA-60670 | Loan Disb | 8,140.17 |
Dec 10, 2020 | IDA-60670 | Loan Disb | 5,811.00 |
Dec 7, 2020 | IDA-60670 | Loan Disb | 261,926.27 |
Dec 7, 2020 | IDA-60670 | Int Charges | 381.82 |
Dec 7, 2020 | IDA-60670 | Int Charges | 16,373.50 |
Dec 7, 2020 | IDA-60670 | Int Charges | 16,373.50 |
Dec 7, 2020 | IDA-60670 | Int Charges | 26,480.83 |
Dec 14, 2020 | IDA-60670 | Loan Disb | 13,313.29 |
Dec 10, 2020 | IDA-60670 | Loan Disb | 11,482.07 |
Sep 9, 2020 | IDA-60670 | Loan Disb | 11,482.08 |
Nov 17, 2020 | IDA-60670 | Loan Disb | 9,684.62 |
Jul 29, 2020 | IDA-60670 | Loan Disb | 10,234.71 |
Aug 25, 2020 | IDA-60670 | Loan Disb | 5,695.15 |
Oct 5, 2020 | IDA-60670 | Loan Disb | 11,452.88 |
Oct 19, 2020 | IDA-60670 | Loan Disb | 9,066.87 |
Jun 2, 2020 | IDA-60670 | Loan Disb | 8,320.00 |
Jun 30, 2020 | IDA-60670 | Loan Disb | 12,893.65 |
Jun 23, 2020 | IDA-60670 | Loan Disb | 13,056.91 |
Sep 25, 2020 | IDA-60670 | Loan Disb | 20,860.45 |
Sep 1, 2020 | IDA-60670 | Loan Disb | 6,805.50 |
Jul 27, 2020 | IDA-60670 | Loan Disb | 13,589.53 |
Aug 19, 2020 | IDA-60670 | Loan Disb | 12,011.67 |
May 7, 2020 | IDA-60670 | Loan Disb | 32,110.11 |
Jun 4, 2020 | IDA-60670 | Loan Disb | 12,011.66 |
Jun 1, 2020 | IDA-60670 | Int Charges | 1,051.41 |
Jun 1, 2020 | IDA-60670 | Int Charges | 14,815.78 |
Jun 1, 2020 | IDA-60670 | Int Charges | 14,815.78 |
Jun 1, 2020 | IDA-60670 | Int Charges | 24,328.10 |
May 26, 2020 | IDA-60670 | Loan Disb | 7,714.03 |
Apr 2, 2020 | IDA-60670 | Loan Disb | 24,109.24 |
Apr 15, 2020 | IDA-60670 | Loan Disb | 13,128.89 |
Apr 9, 2020 | IDA-60670 | Loan Disb | 11,794.53 |
Feb 25, 2020 | IDA-60670 | Loan Disb | 11,794.52 |
Jan 23, 2020 | IDA-60670 | Loan Disb | 15,582.04 |
May 8, 2020 | IDA-60670 | Loan Disb | 11,794.53 |
Dec 3, 2019 | IDA-60670 | Loan Disb | 21,221.00 |
Sep 14, 2022 | IDA-60670 | Loan Disb | 8,319.49 |
Sep 14, 2022 | IDA-60670 | Loan Disb | 10,681.17 |
Dec 21, 2021 | IDA-60670 | Loan Disb | 23,599.88 |
Oct 4, 2022 | IDA-60670 | Loan Disb | 10,167.28 |
Jan 28, 2022 | IDA-60670 | Loan Disb | 7,161.63 |
Jul 29, 2022 | IDA-60670 | Loan Disb | 11,982.35 |
Dec 30, 2022 | IDA-60670 | Loan Disb | 9,562.46 |
May 25, 2022 | IDA-60670 | Loan Disb | 10,056.75 |
Jun 1, 2022 | IDA-60670 | Loan Repay | 530.90 |
Jun 1, 2022 | IDA-60670 | Loan Repay | 246,564.10 |
May 11, 2022 | IDA-60670 | Loan Disb | 7,416.73 |
Jun 1, 2022 | IDA-60670 | Int Charges | 35,721.33 |
Jun 1, 2022 | IDA-60670 | Int Charges | 21,432.78 |
Jun 1, 2022 | IDA-60670 | Int Charges | 21,432.78 |
Dec 21, 2021 | IDA-60670 | Int Charges | 18,941.49 |
Dec 21, 2021 | IDA-60670 | Int Charges | 18,941.49 |
Dec 21, 2021 | IDA-60670 | Int Charges | 31,569.17 |
Dec 21, 2021 | IDA-60670 | Int Charges | 498.96 |
Apr 8, 2022 | IDA-60670 | Loan Disb | 265,166.47 |
Dec 7, 2021 | IDA-60670 | Loan Disb | 199,152.90 |
Dec 7, 2021 | IDA-60670 | Loan Disb | 21,057.15 |
Dec 7, 2021 | IDA-60670 | Loan Disb | 221,399.62 |
Dec 7, 2021 | IDA-60670 | Loan Disb | 264,422.62 |
Dec 15, 2021 | IDA-60670 | Loan Disb | 41,226.22 |
May 27, 2022 | IDA-60670 | Loan Disb | 63,192.65 |
Mar 22, 2022 | IDA-60670 | Loan Disb | 4,054.97 |
Feb 22, 2022 | IDA-60670 | Loan Disb | 9,637.04 |
Mar 11, 2022 | IDA-60670 | Loan Disb | 8,333.15 |
May 31, 2022 | IDA-60670 | Loan Disb | 41,659.08 |
Sep 2, 2021 | IDA-60670 | Loan Disb | 11,423.45 |
Nov 12, 2021 | IDA-60670 | Loan Disb | 10,723.45 |
Mar 25, 2021 | IDA-60670 | Loan Disb | 355,592.50 |
Jun 9, 2021 | IDA-60670 | Loan Disb | 11,482.07 |
Jun 17, 2021 | IDA-60670 | Int Charges | 29,714.33 |
Apr 28, 2021 | IDA-60670 | Loan Disb | 6,298.50 |
Jun 17, 2021 | IDA-60670 | Int Charges | 805.22 |
Jun 17, 2021 | IDA-60670 | Int Charges | 18,134.93 |
Jun 17, 2021 | IDA-60670 | Int Charges | 18,134.93 |
Jul 28, 2021 | IDA-60670 | Loan Disb | 24,449.85 |
Jul 23, 2021 | IDA-60670 | Loan Disb | 11,452.88 |
Jan 30, 2024 | IDA-60670 | Loan Disb | 33,580.04 |
Jan 30, 2024 | IDA-60670 | Loan Disb | 64,474.04 |
Jan 30, 2024 | IDA-60670 | Loan Disb | 11,572.74 |
Feb 2, 2024 | IDA-60670 | Loan Disb | 10,381.28 |
Feb 2, 2024 | IDA-60670 | Loan Disb | 1,311,858.00 |
Feb 1, 2024 | IDA-60670 | Loan Disb | 160,718.27 |
Mar 7, 2024 | IDA-60670 | Loan Disb | 364,294.70 |
Apr 24, 2024 | IDA-60670 | Loan Disb | 10,283.63 |
Apr 24, 2024 | IDA-60670 | Loan Disb | 43,374.01 |
Feb 22, 2024 | IDA-60670 | Loan Disb | 385,723.80 |
Mar 21, 2024 | IDA-60670 | Loan Disb | 50,611.65 |
Apr 16, 2024 | IDA-60670 | Loan Disb | 18,276.27 |
Apr 16, 2024 | IDA-60670 | Loan Disb | 44,632.70 |
Apr 16, 2024 | IDA-60670 | Loan Disb | 31,477.60 |
Apr 16, 2024 | IDA-60670 | Loan Disb | 35,654.85 |
Apr 16, 2024 | IDA-60670 | Loan Disb | 26,284.61 |
Jun 18, 2024 | IDA-60670 | Loan Disb | 33,265.85 |
May 17, 2024 | IDA-60670 | Loan Disb | 124,680.18 |
Apr 3, 2024 | IDA-60670 | Loan Disb | 59,326.35 |
Aug 9, 2024 | IDA-60670 | Loan Disb | 35,055.91 |
Jul 19, 2024 | IDA-60670 | Loan Disb | 793,620.56 |
Aug 22, 2024 | IDA-60670 | Loan Disb | 106,263.19 |
Apr 3, 2024 | IDA-60670 | Loan Disb | 19,852.35 |
Jul 9, 2024 | IDA-60670 | Loan Disb | 35,055.91 |
Mar 19, 2024 | IDA-60670 | Loan Disb | 10,825.27 |
Jan 30, 2024 | IDA-60670 | Loan Disb | 43,123.87 |
Jan 23, 2024 | IDA-60670 | Loan Disb | 69,792.17 |
Jan 23, 2024 | IDA-60670 | Loan Disb | 566,716.00 |
Jan 23, 2024 | IDA-60670 | Loan Disb | 77,692.52 |
Nov 14, 2023 | IDA-60670 | Loan Disb | 17,816.19 |
Oct 23, 2023 | IDA-60670 | Loan Disb | 14,670.67 |
Jun 14, 2024 | IDA-60670 | Loan Disb | 26,948.39 |
Jun 14, 2024 | IDA-60670 | Loan Disb | 100,316.47 |
Aug 20, 2024 | IDA-60670 | Loan Disb | 111,561.43 |
Apr 3, 2024 | IDA-60670 | Loan Disb | 20,985.87 |
Jun 14, 2024 | IDA-60670 | Loan Disb | 59,010.17 |
Jun 14, 2024 | IDA-60670 | Loan Disb | 129,144.26 |
Jun 14, 2024 | IDA-60670 | Loan Disb | 18,397.32 |
Apr 12, 2024 | IDA-60670 | Loan Disb | 49,303.17 |
Jun 14, 2024 | IDA-60670 | Loan Disb | 45,349.96 |
Apr 12, 2024 | IDA-60670 | Loan Disb | 175,968.00 |
Jul 9, 2024 | IDA-60670 | Loan Disb | -34,995.07 |
Nov 3, 2023 | IDA-60670 | Loan Disb | 37,640.37 |
Nov 22, 2023 | IDA-60670 | Loan Disb | 8,222.52 |
Dec 1, 2023 | IDA-60670 | Int Charges | 24,987.83 |
Dec 1, 2023 | IDA-60670 | Int Charges | 37,230.29 |
Dec 1, 2023 | IDA-60670 | Loan Repay | 240,372.98 |
Dec 1, 2023 | IDA-60670 | Int Charges | 24,987.83 |
Dec 1, 2023 | IDA-60670 | Loan Repay | 3,630.44 |
Nov 20, 2023 | IDA-60670 | Loan Disb | 43,368.30 |
Dec 20, 2023 | IDA-60670 | Loan Disb | 28,406.26 |
Jan 8, 2024 | IDA-60670 | Loan Disb | 31,788.40 |
Oct 4, 2023 | IDA-60670 | Loan Disb | 25,206.90 |
Oct 16, 2023 | IDA-60670 | Loan Disb | 53,074.06 |
Oct 26, 2023 | IDA-60670 | Loan Disb | 18,965.43 |
Jun 1, 2023 | IDA-60670 | Int Charges | 11,983.29 |
Jun 1, 2023 | IDA-60670 | Loan Repay | 243,585.84 |
Jun 1, 2023 | IDA-60670 | Int Charges | 39.55 |
Jun 1, 2023 | IDA-60670 | Int Charges | 39.55 |
Jul 17, 2023 | IDA-60670 | Loan Disb | 533,286.00 |
Jun 1, 2023 | IDA-60670 | Int Charges | 22,853.09 |
Jun 1, 2023 | IDA-60670 | Int Charges | 22,853.09 |
Jun 1, 2023 | IDA-60670 | Int Charges | 38,088.51 |
Jun 1, 2023 | IDA-60670 | Int Charges | 65.91 |
Dec 1, 2023 | IDA-60670 | Loan Disb | 53,700.00 |
Jun 1, 2023 | IDA-60670 | Loan Disb | 315,700.00 |
Jun 20, 2023 | IDA-60670 | Loan Disb | 14,584.46 |
Sep 1, 2023 | IDA-60670 | Loan Disb | 14,584.45 |
Jul 19, 2023 | IDA-60670 | Loan Disb | 14,584.46 |
Sep 15, 2023 | IDA-60670 | Loan Disb | 14,718.44 |
Mar 28, 2023 | IDA-60670 | Loan Disb | 14,438.43 |
Sep 26, 2022 | IDA-60670 | Loan Disb | 246,396.95 |
Dec 1, 2022 | IDA-60670 | Loan Repay | 6,230.42 |
Dec 9, 2022 | IDA-60670 | Loan Repay | 237,132.19 |
Dec 9, 2022 | IDA-60670 | Int Charges | 22,210.44 |
Dec 9, 2022 | IDA-60670 | Int Charges | 22,210.44 |
Dec 9, 2022 | IDA-60670 | Int Charges | 25,043.18 |
Mar 8, 2023 | IDA-60670 | Loan Disb | 14,623.40 |
Oct 6, 2022 | IDA-60670 | Loan Disb | 263,926.22 |
Dec 12, 2022 | IDA-60670 | Loan Disb | 15,436.32 |
Jun 18, 2019 | IDA-60670 | Loan Disb | 1,799,787.00 |
Jun 17, 2019 | IDA-60670 | Loan Disb | 13,697.38 |
Apr 26, 2019 | IDA-60670 | Loan Disb | 6,706.69 |
May 21, 2018 | IDA-60670 | Loan Disb | 62,300.00 |
Feb 6, 2019 | IDA-60670 | Loan Disb | 14,213.91 |
Dec 13, 2018 | IDA-60670 | Loan Disb | 311,450.00 |
Feb 6, 2019 | IDA-60670 | Loan Disb | 13,697.38 |
Dec 4, 2018 | IDA-60670 | Int Charges | 12.70 |
Dec 4, 2018 | IDA-60670 | Int Charges | 12.70 |
Dec 4, 2018 | IDA-60670 | Int Charges | 21.16 |
Dec 1, 2019 | IDA-60670 | Int Charges | 4.52 |
Dec 1, 2019 | IDA-60670 | Int Charges | 4.52 |
Dec 4, 2019 | IDA-60670 | Loan Disb | 11,794.54 |
Dec 1, 2019 | IDA-60670 | Int Charges | 12,172.06 |
Jan 15, 2020 | IDA-60670 | Loan Disb | 11,794.53 |
Jan 21, 2020 | IDA-60670 | Loan Disb | 6,906.25 |
Feb 27, 2020 | IDA-60670 | Loan Disb | 29,503.48 |
Dec 12, 2019 | IDA-60670 | Loan Disb | 12,350.00 |
Dec 1, 2019 | IDA-60670 | Int Charges | 12,172.06 |
Dec 1, 2019 | IDA-60670 | Int Charges | 19,241.61 |
Mar 23, 2020 | IDA-60670 | Loan Disb | 17,000.31 |
Mar 19, 2020 | IDA-60670 | Loan Disb | 11,794.52 |
Mar 9, 2020 | IDA-60670 | Loan Disb | 7,393.76 |
Aug 22, 2019 | IDA-60670 | Loan Disb | 8,603.16 |
Oct 24, 2019 | IDA-60670 | Loan Disb | 259,946.02 |
Nov 27, 2019 | IDA-60670 | Loan Disb | 6,494.28 |
Sep 20, 2019 | IDA-60670 | Loan Disb | 17,346.88 |
Oct 15, 2019 | IDA-60670 | Loan Disb | 13,697.38 |
Sep 20, 2019 | IDA-60670 | Loan Disb | 8,848.34 |
Jun 1, 2019 | IDA-60670 | Int Charges | 178.37 |
Jun 1, 2019 | IDA-60670 | Int Charges | 2,888.99 |
Jun 1, 2019 | IDA-60670 | Int Charges | 2,888.99 |
Nov 1, 2019 | IDA-60670 | Loan Disb | 18,646.60 |
Nov 7, 2019 | IDA-60670 | Loan Disb | 41,860.00 |
Jul 26, 2019 | IDA-60670 | Loan Disb | 25,394.76 |
Nov 15, 2019 | IDA-60670 | Loan Disb | 13,253.04 |
Oct 22, 2019 | IDA-60670 | Loan Disb | 10,075.00 |
Oct 22, 2019 | IDA-60670 | Loan Disb | 45,149.00 |
Sep 11, 2019 | IDA-60670 | Loan Disb | 27,394.75 |
Jun 1, 2019 | IDA-60670 | Int Charges | 4,815.00 |
Nov 20, 2019 | IDA-60670 | Loan Disb | 24,414.86 |
Aug 28, 2019 | IDA-60670 | Loan Disb | 26,934.39 |
Dec 4, 2018 | IDA-60670 | Int Charges | 228.52 |
Dec 4, 2018 | IDA-60670 | Int Charges | 228.52 |
Dec 4, 2018 | IDA-60670 | Int Charges | 201.22 |
Mar 12, 2019 | IDA-60670 | Loan Disb | 13,697.38 |
Mar 20, 2019 | IDA-60670 | Loan Disb | 599,930.00 |
Mar 25, 2019 | IDA-60670 | Loan Disb | 434,485.00 |
Jun 27, 2019 | IDA-60670 | Loan Disb | 29,167.89 |
Apr 5, 2019 | IDA-60670 | Loan Disb | 13,697.38 |
Name | Review | Date |
---|---|---|
Financial Management | Moderately Satisfactory | 2024-06-14 |
Overall Safeguards Rating | Moderately Unsatisfactory | 2024-06-14 |
Progress towards achievement of PDO | Satisfactory | 2024-06-14 |
Project Management | Satisfactory | 2024-06-14 |
Monitoring and Evaluation | Satisfactory | 2024-06-14 |
Overall Implementation Progress (IP) | Satisfactory | 2024-06-14 |
Procurement | Moderately Satisfactory | 2024-06-14 |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Number of people receiving tuberculosis treatment in accordance with the national guidelines (NCD) | Value | 6169.00 | 3358.00 | 7100.00 |
Date | August 31, 2016 | June 30, 2023 | March 31, 2024 | |
Comment |
Number of people receiving tuberculosis treatment in accordance with national guidelines (Daru, Western Province) | Value | 480.00 | 133.00 | 612.00 |
Date | August 31, 2016 | March 31, 2023 | March 31, 2024 | |
Comment |
Proportion of new and relapse TB patients tested using a WHO-recommended rapid test (GeneXpert) at time of diagnosis (NCD) | Value | 10.00 | 66.00 | 90.00 |
Date | August 31, 2016 | June 30, 2023 | March 31, 2024 | |
Comment |
Proportion of new and relapse TB patients tested using a WHO-recommended rapid test (GeneXpert) at time of diagnosis (Daru, WesternProvince) | Value | 10.00 | 96.00 | 90.00 |
Date | August 31, 2016 | March 31, 2023 | March 31, 2024 | |
Comment |
TB treatment success rate for DS TB (NCD) | Value | 56.00 | 89.50 | 85.00 |
Date | August 31, 2016 | June 30, 2023 | March 31, 2024 | |
Comment |
TB treatment success rate for DR TB (NCD) | Value | 44.00 | 52.00 | 75.00 |
Date | August 31, 2016 | December 31, 2022 | March 31, 2024 | |
Comment |
TB treatment success rate for DR TB for females (NCD) | Value | 0.00 | 68.00 | 75.00 |
Date | August 31, 2016 | December 31, 2022 | March 31, 2024 | |
Comment |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Population-based screening in Daru is complete | Value | No | Yes | Yes |
Date | August 31, 2016 | December 31, 2021 | March 31, 2024 | |
Comment |
Culture conversion rate among DR TB cases (NCD) | Value | 0.00 | 47.00 | 75.00 |
Date | August 31, 2016 | December 31, 2021 | March 31, 2024 | |
Comment |
Timely delivery of annual report compiled by NTP | Value | No | Yes | Yes |
Date | August 31, 2016 | June 30, 2023 | March 31, 2024 | |
Comment |
Population-based screening in NCD is ongoing | Value | No | No | Yes |
Date | January 1, 2022 | June 30, 2023 | March 31, 2024 | |
Comment |
Number of BMUs using e-health information system for TB case and laboratory management in targeted geographic areas (NCD & Western Province) | Value | 0.00 | 14.00 | 20.00 |
Date | August 31, 2016 | June 30, 2023 | March 31, 2024 | |
Comment |
Number of BMUs with functioning TB Smear microscopy (NCD) | Value | 7.00 | 7.00 | 14.00 |
Date | August 31, 2016 | June 30, 2023 | March 31, 2024 | |
Comment |
Carry out semi-annual review meeting which involves TB development partners and government agencies to review the progress and makethe consolidated integrated work plan and budget | Value | No | No | Yes |
Date | August 31, 2016 | June 30, 2023 | March 31, 2024 | |
Comment |
Number of BMUs with functioning TB Smear microscopy (Western Province) | Value | 2.00 | 6.00 | 6.00 |
Date | August 31, 2016 | June 30, 2023 | March 31, 2024 | |
Comment |
Citizens and/or communities involved in planning/ implementation/ evaluation of development programs | Value | No | Yes | Yes |
Date | August 31, 2016 | December 31, 2022 | March 31, 2024 | |
Comment |
Number of BMUs with functioning GeneXpert (NCD) | Value | 3.00 | 7.00 | 14.00 |
Date | August 31, 2016 | March 31, 2023 | March 31, 2024 | |
Comment |
A reduction in lost to follow up of DS TB patients (NCD) | Value | 10.00 | 4.00 | 5.00 |
Date | August 31, 2016 | June 30, 2023 | March 31, 2024 | |
Comment |
Project-supported organization(s) publishing reports containing information on feedback received from citizens and/or communities and if/how this feedback has been used | Value | No | Yes | Yes |
Date | August 31, 2016 | June 30, 2023 | March 31, 2024 | |
Comment |
Number of BMUs with functioning GeneXpert (Western Province) | Value | 2.00 | 8.00 | 6.00 |
Date | August 31, 2016 | June 30, 2023 | March 31, 2024 | |
Comment |
A reduction in lost to follow up of DR TB patients (NCD) | Value | 12.00 | 10.00 | 5.00 |
Date | August 31, 2016 | December 31, 2022 | March 31, 2024 | |
Comment |
Number of BMUs where all clinical staff have been trained/retrained on TB and DR TB (NCD and Western Province) | Value | 0.00 | 20.00 | 20.00 |
Date | August 31, 2016 | June 30, 2023 | March 31, 2024 | |
Comment |